Table 1 Clinical and pathologic data of patients included in the study stratified by uterine cancer histologic subtype
Total (N = 113) | Benigna (N = 22) | G1 EAC (N = 16) | G2 EAC (N = 15) | G3 EAC (N = 16) | UPSC (N = 15) | CS (N = 15) | LMS (N = 8) | CCC (N = 6) | |
|---|---|---|---|---|---|---|---|---|---|
Age | 62.2 ± 11.7 | 55.6 ± 13.1 | 65.0 ± 11.6 | 62.4 ± 9.2 | 63.4 ± 10.2 | 71.5 ± 5.7 | 65.5 ± 6.4 | 50.6 ± 12.1 | 58.3 ± 14.6 |
Race | |||||||||
White | 57 (50) | 13 (59) | 11 (69) | 8 (53) | 9 (56) | 4 (27) | 6 (40) | 3 (38) | 3 (50) |
Black | 49 (43) | 7 (32) | 5 (31) | 6 (40) | 3 (19) | 11 (73) | 9 (60) | 5 (62) | 3 (50) |
Asian | 7 (6) | 2 (9) | 0 (0) | 1 (7) | 4 (25) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Hispanic | 36 (32) | 5 (23) | 6 (38) | 7 (47) | 6 (38) | 2 (13) | 5 (33) | 3 (38) | 2 (33) |
Body mass index (kg/m2) | 31.1 (24.2, 37.0) | 31.1 (23.2, 38.8) | 32.3 (27.7, 43.5) | 33.4 (28.0, 42.1) | 27.5 (21.6, 37.2) | 26.1 (21.8, 33.8) | 30.7 (22.3, 37.1) | 27.4 (25.3, 33.5) | 34.7 (27.5, 39.1) |
Stageb | |||||||||
I | 41 (45) | – | 10 (63) | 11 (73) | 8 (50) | 1 (7) | 3 (20) | 3 (38) | 5 (83) |
II | 16 (18) | – | 4 (25) | 2 (13) | 1 (6) | 6 (40) | 1 (7) | 1 (13) | 1 (17) |
III | 22 (24) | – | 0 (0) | 2 (13) | 7 (44) | 6 (40) | 6 (40) | 1 (13) | 0 (0) |
IV | 12 (13) | – | 2 (13) | 0 (0) | 0 (0) | 2 (13) | 5 (33) | 3 (38) | 0 (0) |
Tumor size (cm)b | 5.5 (3.5, 8.7) | – | 3.9 (2.7, 5.2) | 4.5 (3.5, 9.0) | 5.3 (3.3, 8.0) | 7.5 (5.2, 9.0) | 8.5 (4.8, 10.0) | 9.5 (5.8, 12.3) | 4.5 (3.5, 6.0) |
Percent myometrial invasionb | 33.0 (12.5, 79.0) | – | 28.5 (13.5, 51.5) | 21.0 (10.0, 45.0) | 57.5 (22.0, 88.8) | 61.0 (13.0, 87.0) | 18.0 (6.0, 40.0) | 100.0 (97.5, 100) | 9.5 (0, 55.0) |
Lymphovascular space invasionb | 40 (44) | – | 4 (25) | 3 (20) | 8 (56) | 10 (67) | 6 (40) | 8 (100) | 0 (0) |
Lymph node involvementb | 22 (24) | – | 1 (6) | 0 (0) | 6 (38) | 9 (60) | 6 (40) | 0 (0) | 0 (0) |